Drug intelligence / Profile preview

muscimol

Development stage
Phase 1
Lead developer
Psyched Wellness
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Muscimol is a naturally occurring psychoactive compound found in mushrooms of the genus Amanita, notably *Amanita muscaria*. It is a potent and selective orthosteric agonist for the Gamma-aminobutyric acid type A receptor (GABA-A receptor), mimicking the action of gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the central nervous system. Muscimol binds to the same site on GABA-A receptors as GABA itself and also acts as a partial agonist at Gamma-aminobutyric acid type C receptor (GABA-C receptor, now known as GABA-A-rho receptor). Its pharmacological effects include sedative-hypnotic, depressant, hallucinogenic, neuroprotective, anti-nociceptive, and anti-epileptic activity. Muscimol has been investigated in clinical trials for epilepsy and Parkinson's disease but is not approved for any medical use. It is considered investigational and has been used recreationally for its psychoactive properties[1][2][3][6].

Other names
5-(aminomethyl)-3(2H)-isoxazolonemuscimol hydrobromide
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on muscimol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on muscimol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call